Patents by Inventor Timo Kalevi Korpela

Timo Kalevi Korpela has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9463457
    Abstract: The invention describes simple and reliable cartridge constructions for carrying out analytical procedures in a closed system, especially for carrying out bioaffinity analyses. The cartridge exploits a measuring component, or a test strip (1 in FIG. 1) and its cover (2 in FIG. 1) as well as the motion between these two components to achieve liquid flow and events which are necessary for the analysis.
    Type: Grant
    Filed: February 1, 2013
    Date of Patent: October 11, 2016
    Assignee: Conventa Ltd.
    Inventor: Timo Kalevi Korpela
  • Patent number: 9176092
    Abstract: Electrochemiluminescent technique and device suitable for cheap analytical and diagnostic applications, with electrodes manufactured from carbon paste and terbium chelates as labeling compounds.
    Type: Grant
    Filed: June 10, 2011
    Date of Patent: November 3, 2015
    Assignee: LABMASTER OY
    Inventors: Sakari Kulmala, Timo Kalevi Korpela, Jarkko Uolevi Eskola, Johanna Suomi, Markus Hakansson, Teppo Tapani Laaksonen
  • Publication number: 20150017641
    Abstract: The invention describes simple and reliable cartridge constructions for carrying out analytical procedures in a closed system, especially for carrying out bioaffinity analyses. The cartridge exploits a measuring component, or a test strip (1 in FIG. 1) and its cover (2 in FIG. 1) as well as the motion between these two components to achieve liquid flow and events which are necessary for the analysis.
    Type: Application
    Filed: February 1, 2013
    Publication date: January 15, 2015
    Inventor: Timo Kalevi KORPELA
  • Patent number: 8920718
    Abstract: The invention describes novel chemiluminescence electrode devices and their novel properties to enable achieving luminescence signal by electrical excitation by cathodic or bipolar pulses in aqueous electrolyte solutions. These devices form a significant improvement in construction of cheap and reliable means for especially diagnosis of health conditions in point-of-need purposes.
    Type: Grant
    Filed: June 10, 2011
    Date of Patent: December 30, 2014
    Assignee: Labmaster Oy
    Inventors: Sakari Kulmala, Timo Kalevi Korpela, Jarkko Uolevi Eskola, Teppo Tapani Laaksonen
  • Publication number: 20130206610
    Abstract: Electrochemiluminescent technique and device suitable for cheap analytical and diagnostic applications, with electrodes manufactured from carbon paste and terbium chelates as labeling compounds.
    Type: Application
    Filed: June 10, 2011
    Publication date: August 15, 2013
    Applicant: LABMASTER OY
    Inventors: Sakari Kulmala, Timo Kalevi Korpela, Jarkko Uolevi Eskola, Johanna Suomi, Markus Hakansson, Teppo Tapani Laaksonen
  • Publication number: 20130199945
    Abstract: The invention describes novel chemiluminescence electrode devices and their novel properties to enable achieving luminescence signal by electrical excitation by cathodic or bipolar pulses in aqueous electrolyte solutions. These devices form a significant improvement in construction of cheap and reliable means for especially diagnosis of health conditions in point-of-need purposes.
    Type: Application
    Filed: June 10, 2011
    Publication date: August 8, 2013
    Applicant: LABMASTER OY
    Inventors: Sakari Kulmala, Timo Kalevi Korpela, Jarkko Uolevi Eskola, Teppo Tapani Laaksonen
  • Patent number: 8382968
    Abstract: A conductor/insulator/porous film device is provided which is used in electrochemiluminescence methods and instrumentation based on the chemical excitation of label molecules with subsequent measurement of the luminescence in order to quantitate analyte concentrations especially in bioaffinity assays.
    Type: Grant
    Filed: March 30, 2006
    Date of Patent: February 26, 2013
    Assignee: Labmaster Ltd.
    Inventors: Timo Väinö Kalevi Ala-Kleme, Jarkko Uolevi Eskola, Timo Kalevi Korpela, Sakari Mikael Kulmala, Piia Kaarina Mäkinen
  • Publication number: 20090178924
    Abstract: A conductor/insulator/porous film device is provided which is used in electrochemiluminescence methods and instrumentation based on the chemical excitation of label molecules with subsequent measurement of the luminescence in order to quantitate analyte concentrations especially in bioaffinity assays.
    Type: Application
    Filed: March 30, 2006
    Publication date: July 16, 2009
    Applicant: LABMASTER LTD.
    Inventors: Timo Väinö Kalevi Ala-Kleme, Jarkko Uolevi Eskola, Timo Kalevi Korpela, Sakari Mikael Kulmala, Piia Kaarina Mäkinen
  • Patent number: 7544773
    Abstract: The present invention provides antimicrobials for efficient therapy of infections caused by bacterial pathogens. The antimicrobials include peptides corresponding to the active site of N-terminal extension of subunits composing specific adhesive organelles of virulence of pathogenic bacteria. These antimicrobial peptides inhibit surface expression of adhesive organelles and thus prevent development of infections caused by pathogenic bacteria. The invention describes also effective methods for screening molecules inhibiting the generation of the adhesive organelles.
    Type: Grant
    Filed: July 14, 2003
    Date of Patent: June 9, 2009
    Inventors: Timo Kalevi Korpela, Anton Zavialov, Vladimir Zav'yalov
  • Publication number: 20090142364
    Abstract: The invention describes production of an adjuvant with biological activities related to N-acetylglucosaminyl-?1-4-N-acetylmuramyl-alanyl-D-isoglutamine (GMDP), a commonly used enhancer of the immune response. It was found in the present invention that the drawbacks of GMDP can be avoided by replacing it with a peptide that does not have any direct structural relationship with GMDP.
    Type: Application
    Filed: August 27, 2008
    Publication date: June 4, 2009
    Inventors: Fedor Alexandrovich Brovko, Timo Kalevi Korpela, Alexander Georgievich Laman, Galina Vladimirovna Malakhova, Vladimir Andreevich Nesmeyanov, Igor Leonidovich Rodionov, Anna Olegovna Shepelyakovskaya
  • Patent number: 7446095
    Abstract: The present invention provides structures of small molecules capable of modulating apoptotic cell death. More specifically, the structures relate to the structures of apoptotic active sites of mammalian alpha-fetoprotein (AFP) and albumin. Peptides mimicking the active site contain two sequences, Arg-Gly-Asp and Asp-X-X-Asp, wherein X means any amino acid. These sequences are needed in the same molecule for causing a wide range of biological activities. The peptides can be utilized to suppress apoptotic pathways by inhibiting the cytochrome c-mediated caspase activation. Thus, the peptides can be used to inhibit effects of apoptosis induced by oxidative stress, drugs, cytokines, Fas-ligand, alpha-fetoprotein, used to prevent apoptosis in culturing cells, in organ transplantation, in immunological autoimmune disorders and immunodeficiency syndrome induced by viral infection, or to diminish side cytotoxic effects after chemotherapy and radiation therapy.
    Type: Grant
    Filed: October 7, 2003
    Date of Patent: November 4, 2008
    Inventors: Elena Ivanovna Dudich, Lidia Nikolaevna Semenkova, Igor Vyacheslavovitch Dudich, Edvward Borisovitch Tatulov, Dimitry Lvovicth Zubov, Timo Kalevi Korpela
  • Patent number: 7326684
    Abstract: The present invention is related to novel bioactive pentapeptides, pentarphins, the main indication of which is enhancing phagocytic activity of macrophages against microbes. In particular, the cyclopentapeptide, cyclo(Val-Lys-Gly-Phe-Tyr), termed cyclopeptarphin, was 100 times more active than tuftsin. Cyclopentarphin was non-toxic even at concentrations 1000 times higher than the minimum active dose, while being non-immunogenic. Furthermore, cyclopentarphin is more stable to enzymatic cleavage in vitro as compared to linear pentarphin and tuftsin and, hence, its life span in vivo is also larger than that of linear peptides. High efficacy and safety of cyclopentarphin enable elaboration of novel drugs that enhance the resistance of human and animal organisms to microbes and micro particles.
    Type: Grant
    Filed: January 21, 2003
    Date of Patent: February 5, 2008
    Inventors: Timo Kalevi Korpela, Elena Navalotskaya, Tatiana Zargarova, Vladimir Zavialov
  • Publication number: 20040177400
    Abstract: The present invention provides constructs and methods for increasing the content of selected amino acids by targeted expression or accumulation of a protein enriched with an amino acid sequence entailing said protein in a plant species or in a tissue or an organ of a plant. The increased content is obtained by stable transformation of plants with a recombinant nucleotide sequence construct encoding a carrier protein having in its 3′-terminal end a polyamino acid extension and operably linked with a tissue or an organ specific regulatory sequence. The increased amino acid content in plant tissues, particularly membraneous oil bodies and cell walls of seed provides a composition useful as animal feed.
    Type: Application
    Filed: February 27, 2004
    Publication date: September 9, 2004
    Inventors: Tony Mikaer Wahlroos, Josif Grigorievieh Atabekov, Yurii Leonidivich Dorokhov, Petri Eerik Susi, Mauri Jaakko Makela, Timo Kalevi Korpela